GeneDx
Runs exome and genome testing for pediatric and rare-disease diagnosis.
$87.15
After-hours close+0.80 (+0.93%)
At close$86.35(−3.24%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Oct 2026 | $0.07 | — | — |
| Aug 2026 | −$0.19 | $0.01 | +105.3% |
| May 2026 | −$0.06 | −$0.28 | −366.7% |
| Feb 2026 | $0.11 | $0.14 | +27.3% |
| Oct 2025 | $0.28 | $0.49 | +75.0% |
The latest year is open to everyone — the 20 quarters behind it read with an account. Sign in | |||
| Jul 2025 | |||
| Apr 2025 | |||
| Feb 2025 | |||
| Oct 2024 | |||
| Jul 2024 | |||
| Apr 2024 | |||
| Feb 2024 | |||
| Oct 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Jul 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Sep 2020 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Oct 27, 2026 | $0.07 | — | — | $123.0M | — | — |
| Aug 3, 2026 | −$0.19 | $0.01 | +105.3% | $111.0M | $114.4M | +3.1% |
| May 4, 2026 | −$0.06 | −$0.28 | −366.7% | $112.5M | $102.3M | −9.1% |
| Feb 23, 2026 | $0.11 | $0.14 | +27.3% | $120.3M | $121.0M | +0.6% |
| Oct 28, 2025 | $0.28 | $0.49 | +75.0% | $120.5M | $116.7M | −3.1% |
The latest year is open to everyone — the 20 quarters behind it read with an account. Sign in | ||||||
| Jul 29, 2025 | ||||||
| Apr 30, 2025 | ||||||
| Feb 18, 2025 | ||||||
| Oct 29, 2024 | ||||||
| Jul 30, 2024 | ||||||
| Apr 29, 2024 | ||||||
| Feb 20, 2024 | ||||||
| Oct 30, 2023 | ||||||
| Aug 8, 2023 | ||||||
| May 9, 2023 | ||||||
| Mar 14, 2023 | ||||||
| Nov 14, 2022 | ||||||
| Aug 15, 2022 | ||||||
| May 12, 2022 | ||||||
| Mar 14, 2022 | ||||||
| Nov 15, 2021 | ||||||
| Jul 21, 2021 | ||||||
| May 24, 2021 | ||||||
| Mar 30, 2021 | ||||||
| Sep 30, 2020 | ||||||